29 results on '"Ohkubo, Yu"'
Search Results
2. Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes
- Author
-
Isohashi, Fumiaki, Yoshida, Ken, Murakami, Naoya, Masui, Koji, Ishihara, Shunichi, Ohkubo, Yu, Kaneyasu, Yuko, Kinoshita, Rumiko, Kotsuma, Tadayuki, Takaoka, Yuji, Tanaka, Eiichi, Nagao, Ayaka, Ogawa, Kazuhiko, and Yamazaki, Hideya
- Published
- 2024
- Full Text
- View/download PDF
3. Conversion from dose length product to effective dose for the CT component of whole-body PET/CT
- Author
-
Inoue, Yusuke, Ohkubo, Yu, Nagahara, Kazunori, Uehara, Ayuka, and Takano, Makoto
- Published
- 2022
- Full Text
- View/download PDF
4. Are prophylactic antibiotics required for combined intracavitary and interstitial brachytherapy of gynecologic cancers?
- Author
-
Kumazawa, Takuya, Ohkubo, Yu, Mochida, Keishiro, Kondo, Saori, Oguchi, Osamu, and Yoshida, Daisaku
- Subjects
INTERSTITIAL brachytherapy ,RADIOISOTOPE brachytherapy ,GYNECOLOGIC cancer ,HIGH dose rate brachytherapy ,ANTIBIOTICS ,TRANSCRANIAL direct current stimulation ,CANCER patients - Abstract
The purpose of this study is to evaluate the need for prophylactic antibiotic treatment prior to combined intracavitary and interstitial (hybrid) brachytherapy for gynecologic cancer. A total of 105 gynecologic cancer patients received 405 brachytherapy sessions, including 302 sessions of intracavitary brachytherapy and 103 sessions of hybrid brachytherapy. Prophylactic antibiotics were administered before 35% of the hybrid brachytherapy sessions. The incidence of postbrachytherapy fever and the frequency of subsequent antibiotic use for infection were compared between treatment groups. Among patients treated with hybrid brachytherapy, fever ≥37.5°C occurred in 16.4% of those not receiving prophylactic antibiotics and 16.7% of those receiving prophylactic antibiotics (P > 0.05). Similarly, fever ≥38.0°C occurred in 4.9% of patients not receiving prophylactic antibiotics and 2.4% of those receiving prophylactic antibiotics (P > 0.05). Additional antibiotics were used to treat postbrachytherapy infections in 4.8% of the group receiving prophylactic antibiotics and 0% of those not receiving prophylactic antibiotics, again without statistically significant difference. There were also no significant differences in posttreatment fever incidence and antibiotics use for infection between intracavitary brachytherapy and hybrid brachytherapy sessions. In conclusion, the incidences of infection and fever are low following hybrid brachytherapy, so prophylactic antibiotics are generally unnecessary. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. The treatment results of definitive radiotherapy for cervical esophageal cancer: a single-institution experience
- Author
-
Ohkubo, Yu, Saito, Yoshihiro, Kudo, Shigehiro, Ushijima, Hiroki, Arima, Miwako, Hara, Hiroki, Yoshii, Takako, Kawashima, Yoshiyuki, Fukuda, Takashi, Oka, Daiji, Tanaka, Yoichi, and Beppu, Takeshi
- Published
- 2017
- Full Text
- View/download PDF
6. Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: a retrospective pooled analysis
- Author
-
Okonogi, Noriyuki, Fukahori, Mai, Wakatsuki, Masaru, Ohkubo, Yu, Kato, Shingo, Miyasaka, Yuhei, Tsuji, Hiroshi, Nakano, Takashi, and Kamada, Tadashi
- Published
- 2018
- Full Text
- View/download PDF
7. Changes in Bone Mineral Density in Uterine Cervical Cancer Patients After Radiation Therapy
- Author
-
Okonogi, Noriyuki, Saitoh, Jun-ichi, Suzuki, Yoshiyuki, Noda, Shin-ei, Ohno, Tatsuya, Oike, Takahiro, Ohkubo, Yu, Ando, Ken, Sato, Hiro, and Nakano, Takashi
- Published
- 2013
- Full Text
- View/download PDF
8. Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer
- Author
-
Kanda, Toshihiro, Fukuda, Syohei, Fukui, Naotaka, Ohkubo, Yu, Kazumoto, Tomoko, Saito, Yoshihiro, Ishikawa, Ayataka, Kurosumi, Masafumi, Kageyama, Yukio, Fujii, Yasuhisa, and Kihara, Kazunori
- Published
- 2016
- Full Text
- View/download PDF
9. Favorable outcome of intraoperative radiotherapy to primary site in patients with metastatic prostate cancer suggests benefits of local therapy: Retrospective study of long-term outcomes in a single Japanese center
- Author
-
Kanda Toshihiro, Fukuda Syohei, Fukui Naotaka, Ohkubo Yu, Kazumoto Tomoko, Saito Yoshihiro, Ishikawa Ayataka, Kurosumi Masafumi, and Kageyama Yukio
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Published
- 2015
- Full Text
- View/download PDF
10. Combining Carbon Ion Radiotherapy and Local Injection of α-Galactosylceramide–Pulsed Dendritic Cells Inhibits Lung Metastases in an In Vivo Murine Model
- Author
-
Ohkubo, Yu, Iwakawa, Mayumi, Seino, Ken-Ichiro, Nakawatari, Miyako, Wada, Haruka, Kamijuku, Hajime, Nakamura, Etsuko, Nakano, Takashi, and Imai, Takashi
- Published
- 2010
- Full Text
- View/download PDF
11. Granulocyte-colony stimulating factor-producing cervical cancers treated with carbon-ion irradiation
- Author
-
Ohkubo, Yu, Kato, Shingo, Kiyohara, Hiroki, Suzuki, Yoshiyuki, Nakano, Takashi, and Kamada, Tadashi
- Published
- 2013
- Full Text
- View/download PDF
12. Change in fibroblast growth factor 2 expression as an early phase radiotherapy-responsive marker in sequential biopsy samples from patients with cervical cancer during fractionated radiotherapy
- Author
-
Nakawatari, Miyako, Iwakawa, Mayumi, Ohno, Tatsuya, Kato, Shingo, Nakamura, Etsuko, Ohkubo, Yu, Tamaki, Tomoaki, and Imai, Takashi
- Published
- 2010
- Full Text
- View/download PDF
13. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
- Author
-
Ohkubo, Yu, Ohno, Tatsuya, Noda, Shin-ei, Kubo, Nobuteru, Nakagawa, Akiko, Kawahara, Masahiro, Abe, Takanori, Kiyohara, Hiroki, Wakatsuki, Masaru, and Nakano, Takashi
- Published
- 2013
- Full Text
- View/download PDF
14. Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report.
- Author
-
Tamaki, Tomoaki, Ohno, Tatsuya, Kiyohara, Hiroki, Noda, Shin-ei, Ohkubo, Yu, Ando, Ken, Wakatsuki, Masaru, Kato, Shingo, Kamada, Tadashi, and Nakano, Takashi
- Subjects
CERVICAL cancer ,RADIOTHERAPY ,RADIOEMBOLIZATION ,LYMPH nodes ,PARTICLE beams - Abstract
Recurrences of cervical cancer after definitive radiotherapy often occur at common iliac or para-aortic lymph nodes as marginal lymph node recurrences. Patients with these recurrences have a chance of long-term survival by optimal re-treatment with radiotherapy. However, the re-irradiation often overlaps the initial and the secondary radiotherapy fields and can result in increased normal tissue toxicities in the bowels or the stomach. Carbon-ion radiotherapy, a form of particle beam radiotherapy using accelerated carbon ions, offers more conformal and sharp dose distribution than X-ray radiotherapy. Therefore, this approach enables the delivery of high radiation doses to the target while sparing its surrounding normal tissues. Marginal lymph node recurrences in common iliac lymph nodes after radiotherapy were treated successfully by carbon-ion radiotherapy in two patients. These two patients were initially treated with a combination of external beam radiotherapy and intracavitary and interstitial brachytherapy. However, the diseases recurred in the lymph nodes near the border of the initial radiotherapy fields after 22 months and 23 months. Because re-irradiation with X-ray radiotherapy may deliver high doses to a section of the bowels, carbon-ion radiotherapy was selected to treat the lymph node recurrences. A total dose of 48 Gy (RBE) in 12 fractions over 3 weeks was given to the lymph node recurrences, and the tumors disappeared completely with no severe acute toxicities. The two patients showed no evidence of disease for 75 months and 63 months after the initial radiotherapy and for 50 months and 37 months after the carbon-ion radiotherapy, respectively. No severe late adverse effects are observed in these patients. The two presented cases suggest that the highly conformal dose distribution of carbon-ion radiotherapy may be beneficial in the treatment of marginal lymph node recurrences after radiotherapy. In addition, the higher biological effect of carbon-ion radiotherapy and its superior dose distribution may provide more effective tumor control in treatment for re-irradiation of the marginal recurrences in radiation resistant tumors other than cervical cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
15. Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity.
- Author
-
Imadome, Kaori, Iwakawa, Mayumi, Nakawatari, Miyako, Fujita, Hidetoshi, Kato, Shingo, Ohno, Tatsuya, Nakamura, Etsuko, Ohkubo, Yu, Tamaki, Tomoaki, Kiyohara, Hiroki, and Imai, Takashi
- Published
- 2010
- Full Text
- View/download PDF
16. Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost for Clinically Node-Positive Prostate Cancer: A Single-Institutional Retrospective Study.
- Author
-
Onishi, Masahiro, Kawamura, Hidemasa, Murata, Kazutoshi, Inoue, Tatsuro, Murata, Hiroto, Takakusagi, Yosuke, Okonogi, Noriyuki, Ohkubo, Yu, Okamoto, Masahiko, Kaminuma, Takuya, Sekihara, Tetsuo, Nakano, Takashi, and Ohno, Tatsuya
- Subjects
ANTIANDROGENS ,RETROSPECTIVE studies ,TREATMENT effectiveness ,RADIATION doses ,KAPLAN-Meier estimator ,DESCRIPTIVE statistics ,RADIOTHERAPY ,COMBINED modality therapy ,PROSTATE tumors - Abstract
Simple Summary: Recently, it has been shown that radiation therapy (RT) together with androgen-depletion therapy (ADT) might be more beneficial compared with ADT alone for clinically node-positive (cN1) prostate cancer. However, there are a limited number of studies that have addressed specific RT techniques and analyzed their clinical results. The present study was a retrospective analysis of cN1 prostate cancer patients treated with intensity-modulated radiation therapy with simultaneous integrated boost (SIB-IMRT), in addition to ADT, in our hospital. The present study suggests that ADT plus SIB-IMRT for cN1 prostate cancer treatment was safe and effective, was well tolerated, and had acceptable rates of late toxicity. Further prospective multicenter studies would be required to confirm the robustness of the present results. This study aimed to evaluate clinical outcomes and the toxicity of intensity-modulated radiation therapy with simultaneous integrated boost (SIB-IMRT) combined with androgen-deprivation therapy for clinically node-positive (cN1) prostate cancer. We retrospectively analyzed 97 patients with cN1 prostate cancer who received SIB-IMRT between June 2008 and October 2017 at our hospital. The prescribed dosages delivered to the prostate and seminal vesicle, elective node area, and residual lymph nodes were 69, 54, and 60 Gy in 30 fractions, respectively. Kaplan–Meier analysis was used to determine 5-year biochemical relapse-free survival (bRFS), relapse-free survival (RFS), overall survival (OS), and prostate cancer-specific survival (PCSS). Toxicity was evaluated using the Common Terminology Criteria for Adverse Events ver. 4.0. Over a median follow-up duration of 60 months, the 5-year bRFS, RFS, OS, and PCSS were 85.1%, 88.1%, 92.7% and 95.0%, respectively. Acute Grade 2 genito-urinary (GU) and gastro-intestinal (GI) toxicities were observed in 10.2% and 2.1%, respectively, with no grade ≥3 toxicities being detected. The cumulative incidence rates of 5-year Grade ≥2 late GU and GI toxicities were 4.7% and 7.4%, respectively, with no Grade 4 toxicities being detected. SIB-IMRT for cN1 prostate cancer demonstrated favorable 5-year outcomes with low incidences of toxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma.
- Author
-
Suzuki, Yoshiyuki, Mimura, Kousaku, Yoshimoto, Yuya, Watanabe, Mitsuaki, Ohkubo, Yu, Izawa, Shinichirou, Murata, Kazutoshi, Fujii, Hideki, Nakano, Takashi, and Kono, Koji
- Subjects
- *
T cells , *ESOPHAGEAL cancer , *LYMPHOCYTES , *SQUAMOUS cell carcinoma , *HIGH mobility group proteins , *CALRETICULIN , *TUMOR antigens , *CANCER treatment - Abstract
Although it has been shown that chemoradiotherapy may induce immunogenic cell death, which could trigger T-cell immunity mediated by high-mobility group box 1 protein (HMGB1) and calreticulin, there is still limited information to support this theory directly in a clinical setting. In the present study, we evaluated antigen-specific T-cell responses against six cancer-testis antigens in peripheral blood lymphocytes from patients with esophageal squamous cell carcinoma (ESCC) receiving chemoradiation. Expression of HMGB1 and calreticulin within tumor microenvironment was also analyzed in resected samples with and without chemoradiotherapy in relation to patients survival. Tumor antigen--specific T-cell responses were confirmed in six (38%) of 16 patients with ESCC after chemoradiotherapy coexisting with elevated serum HMGB1. In addition, HMGB1 within tumor microenvironment was significantly upregulated in patients with ESCC with preoperative chemoradiotherapy, but not in those without chemoradiotherapy, and the degree of HMGB1 positively correlated with patient survival (n = 88). Both irradiation and chemotherapeutic drugs induced upregulation of HMGB1 and calreticulin in nine ESCC cell lines. Furthermore, HMGB1 was able to induce maturation of dendritic cells. Together, our findings indicate that chemoradiation induces tumor antigen--specific T-cell responses, and HMGB1 production is related to clinical outcome after chemoradiation. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
18. Quality of palliative radiotherapy assessed using quality indicators: a multicenter survey†.
- Author
-
Saito T, Shikama N, Takahashi T, Nakamura N, Mori T, Nakajima K, Koizumi M, Sekii S, Ebara T, Kiyohara H, Higuchi K, Yorozu A, Nishimura T, Ejima Y, Harada H, Araki N, Miwa M, Yamada K, Kawamoto T, Imano N, Heianna J, Nozaki M, Wada Y, Ohkubo Y, Uchida N, Watanabe M, Kosugi T, Miyazawa K, Yasuda S, and Onishi H
- Subjects
- Humans, Surveys and Questionnaires, Brain Neoplasms radiotherapy, Bone Neoplasms radiotherapy, Bone Neoplasms secondary, Radiotherapy, Guideline Adherence, Palliative Care, Quality Indicators, Health Care
- Abstract
We sought to identify potential evidence-practice gaps in palliative radiotherapy using quality indicators (QIs), previously developed using a modified Delphi method. Seven QIs were used to assess the quality of radiotherapy for bone metastases (BoM) and brain metastases (BrM). Compliance rate was calculated as the percentage of patients for whom recommended medical care was conducted. Random effects models were used to estimate the pooled compliance rates. Of the 39 invited radiation oncologists, 29 (74%) from 29 centers participated in the survey; 13 (45%) were academic and 16 (55%) were non-academic hospitals. For the QIs, except for BoM-4, the pooled compliance rates were higher than 80%; however, for at least some of the centers, the compliance rate was lower than these pooled rates. For BoM-4 regarding steroid use concurrent with radiotherapy for malignant spinal cord compression, the pooled compliance rate was as low as 32%. For BoM-1 regarding the choice of radiation schedule, the compliance rate was higher in academic hospitals than in non-academic hospitals (P = 0.021). For BrM-3 regarding the initiation of radiotherapy without delay, the compliance rate was lower in academic hospitals than in non-academic hospitals (P = 0.016). In conclusion, overall, compliance rates were high; however, for many QIs, practice remains to be improved in at least some centers. Steroids are infrequently used concurrently with radiotherapy for malignant spinal cord compression., (© The Author(s) 2024. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.)
- Published
- 2024
- Full Text
- View/download PDF
19. Adenoid cystic carcinoma of the orbit without lacrimal gland involvement and with intracranial extension: A case report.
- Author
-
Ohkubo Y, Okubo T, Asari Y, Matsuzaka Y, Kitaguchi M, Shiota S, Fujita R, Okamoto K, Obata H, Kishida Y, and Nagao T
- Abstract
We present a 76-year-old female with a 6-year history of decreased vision in the right eye and right-sided facial neuralgia. She had a T1 isointense and T2 isointense enhancing lesion in the right orbit and the middle cranial fossa on MRI examination. Granulomatous disease or meningioma was suspected, however, after removal, the tumor was identified by pathology as adenoid cystic carcinoma (ACC). The tumor has no radiological and clinical lacrimal grand involvement. ACC shows a slow and indolent growth pattern but is associated with poor long-term outcomes, mainly due to perineural invasion, local control failure, and distant metastasis. This case highlights the importance of a pathologic diagnosis and early intervention in similar presentations., (© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.)
- Published
- 2023
- Full Text
- View/download PDF
20. Repetitive Painting (REPEAT) Irradiation in Stereotactic Radiotherapy Using Helical Tomotherapy.
- Author
-
Ohkubo YU, Kumazawa T, Hirai R, and Noda SE
- Subjects
- Dose Fractionation, Radiation, Humans, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Radiosurgery, Radiotherapy, Intensity-Modulated
- Abstract
Background/aim: Stereotactic radiotherapy (SRT) for spine metastases with helical tomotherapy requires a long irradiation time due to the high dose per fraction. Since helical tomotherapy can neither confirm nor correct the position during irradiation, a plan with a long irradiation time cannot be used in actual clinical practice, given the intra-fractional motion error. To address this problem, we devised a method called REPEAT irradiation., Patients and Methods: REPEtitive pAinTing (REPEAT) irradiation is a method of dividing the irradiation for a given fraction per day into several sessions and performing the irradiation after position correction using mega-voltage computed tomography images for each session. In order to evaluate how REPEAT irradiation changes irradiation time and the dose-volume histogram (DVH), a planning study with helical tomotherapy was conducted using CT images of a patient with lumbar spine metastasis., Results: In this case, we found that dividing 3 irradiation fractions into 3 sessions per day (i.e., 9 fractions=9 sessions in 3 days) using REPEAT irradiation shortened the irradiation time per session and simultaneously improved dose-volume histogram parameters., Conclusion: Although the optimal number of sessions may differ depending on the patient's condition, the fixing method, the irradiation site, and the calculation parameters, REPEAT irradiation does not require any special equipment and is a simple practical treatment method., (Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
21. Time Dependence of Intra-fractional Motion in Spinal Stereotactic Body Radiotherapy.
- Author
-
Hirai R, Ohkubo YU, Igari M, Kumazaki YU, Aoshika T, Ryuno Y, Saito S, Abe T, Noda SE, and Kato S
- Subjects
- Cone-Beam Computed Tomography, Humans, Movement, Radiotherapy Planning, Computer-Assisted, Spine diagnostic imaging, Spine surgery, Radiosurgery
- Abstract
Background/aim: Positional uncertainty in spinal stereotactic body radiotherapy (SBRT) may cause fatal error, therefore, we investigated the intra-fractional spinal motion during SBRT and its time dependency., Patients and Methods: Thirty-one patients who received SBRT using CyberKnife were enrolled in the study. 2D kV X-ray spine images in two directions were taken before and during treatment. Image acquisition intervals during treatment were set at 35-60 sec. Automatic image matchings were performed between the reference digital reconstructed radiography (DRR) and live images, and the spinal position displacements were logged in six translational and rotational directions. If the displacements exceeded 2 mm or 1 degree, the treatment beam delivery was interrupted and the patient position was corrected by moving couch, and the couch adjustments were also logged. Based on the information, the time-dependent accumulated translational and rotational displacements without any couch adjustments were calculated., Results: Spinal position displacements in all translational and rotational directions were correlated with elapsed treatment time. Especially, Right-Left displacements of >1 mm and >2 mm were observed at 4-6 and 8-10 min after treatment initiation, respectively. Rotational displacements in the Yaw direction >1° were observed at 10-15 min after treatment initiation., Conclusion: The translational and rotational displacements systematically increased with elapsed treatment time. It is suggested that the spine position should be checked at least every 4-6 min or the treatment time should be limited within 4-6 minutes to ensure the irradiation accuracy within the millimeter or submillimeter range., (Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
22. Radiotherapy for localized gastric mucosa-associated lymphoid tissue lymphoma: long-term outcomes over 10 years.
- Author
-
Ohkubo Y, Saito Y, Ushijima H, Onishi M, Kazumoto T, Saitoh JI, Kubota N, Kobayashi H, Maseki N, Nishimura Y, and Kurosumi M
- Subjects
- Adult, Aged, Aged, 80 and over, Disease-Free Survival, Dose-Response Relationship, Radiation, Female, Humans, Kaplan-Meier Estimate, Lymphoma, Non-Hodgkin diagnostic imaging, Male, Middle Aged, Neoplasm Metastasis, Stomach Neoplasms diagnostic imaging, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Lymphoma, Non-Hodgkin pathology, Lymphoma, Non-Hodgkin radiotherapy, Stomach Neoplasms pathology, Stomach Neoplasms radiotherapy
- Abstract
This study aimed to assess the long-term outcomes of radiotherapy in patients with localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Twenty-seven patients with Stage I gastric MALT lymphoma were treated with radiotherapy from 1999 to 2010. The median age was 65 years (range: 31-84). Fifteen patients were Helicobacter pylori-negative. Thirteen patients were treated with definitive radiotherapy alone. The other 14 patients who had refractory or residual disease following a prior treatment received salvage radiotherapy. The median dose of the radiotherapy was 30 Gy in 20 fractions (range: 30-39.5 Gy). The median follow-up period was 121 months (range: 8-176 months). The 5- and 10-year overall survival rates for all patients were 92% and 87%, respectively. No patients died from MALT lymphoma. Three patients died of other diseases at 8, 33 and 74 months after radiotherapy (myocardial infarction, pneumonia and hepatocellular carcinoma, respectively). No cases of local recurrence were observed during the follow-up period. There were no serious late gastric, liver or kidney complications during a median follow-up period of over 10 years. Two patients remain alive with distant metastases: a lung metastasis and an abdominal lymph node metastasis at 104 months and 21 months after radiotherapy, respectively. Excellent long-term local control was observed in patients with localized gastric MALT lymphoma after radiotherapy. However, lifelong follow-up should be conducted to detect cases of late recurrence, especially distant metastases., (© Oxford University Press 2017.)
- Published
- 2017
- Full Text
- View/download PDF
23. In-room computed tomography-based brachytherapy for uterine cervical cancer: results of a 5-year retrospective study.
- Author
-
Ohno T, Noda SE, Okonogi N, Murata K, Shibuya K, Kiyohara H, Tamaki T, Ando K, Oike T, Ohkubo Y, Wakatsuki M, Saitoh JI, and Nakano T
- Subjects
- Adult, Aged, Aged, 80 and over, Disease-Free Survival, Dose-Response Relationship, Radiation, Female, Humans, Middle Aged, Pelvis diagnostic imaging, Pelvis pathology, Retrospective Studies, Treatment Outcome, Brachytherapy, Tomography, X-Ray Computed, Uterine Cervical Neoplasms diagnostic imaging, Uterine Cervical Neoplasms radiotherapy
- Abstract
Herein, we investigate the long-term clinical outcomes for cervical cancer patients treated with in-room computed tomography-based brachytherapy. Eighty patients with Stage IB1-IVA cervical cancer, who had undergone treatment with combined 3D high-dose rate brachytherapy and conformal radiotherapy between October 2008 and May 2011, were retrospectively analyzed. External beam radiotherapy (50 Gy) with central shielding after 20-40 Gy was performed for each patient. Cisplatin-based chemotherapy was administered concurrently to advanced-stage patients aged ≤75 years. Brachytherapy was delivered in four fractions of 6 Gy per week. In-room computed tomography imaging with applicator insertion was performed for treatment planning. Information from physical examinations at diagnosis, and brachytherapy and magnetic resonance imaging at diagnosis and just before the first brachytherapy session, were referred to for contouring of the high-risk clinical target volume. The median follow-up duration was 60 months. The 5-year local control, pelvic progression-free survival and overall survival rates were 94%, 90% and 86%, respectively. No significant differences in 5-year local control rates were observed between Stage I, Stage II and Stage III-IVA patients. Conversely, a significant difference in the 5-year overall survival rate was observed between Stage II and III-IVA patients (97% vs 72%; P = 0.006). One patient developed Grade 3 late bladder toxicity. No other Grade 3 or higher late toxicities were reported in the rectum or bladder. In conclusion, excellent local control rates were achieved with minimal late toxicities in the rectum or bladder, irrespective of clinical stage., (© The Author 2016. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.)
- Published
- 2017
- Full Text
- View/download PDF
24. Regulation of Unfolded Protein Response via Protein S-nitrosylation.
- Author
-
Ohkubo Y, Nakato R, and Uehara T
- Subjects
- Animals, Apoptosis, Brain metabolism, Endoplasmic Reticulum Stress, Endoribonucleases genetics, Endoribonucleases metabolism, Mutagenesis, Site-Directed, Neurodegenerative Diseases etiology, Neurodegenerative Diseases metabolism, Protein Serine-Threonine Kinases genetics, Protein Serine-Threonine Kinases metabolism, Ribonucleases metabolism, Endoplasmic Reticulum metabolism, Nitric Oxide physiology, Protein Disulfide-Isomerases metabolism, Protein S metabolism, Unfolded Protein Response
- Abstract
Nitric oxide (NO) plays a pivotal function in neurotransmission, vasodilation, proliferation, and apoptosis in various types of cells via protein S-nitrosylation. Previously we demonstrated that protein disulfide isomerase (PDI) is S-nitrosylated in brains manifesting sporadic neurodegenerative diseases. This modification results in dysfunction of its enzymatic activity and consequently the accumulation of unfolded/misfolded proteins in the endoplasmic reticulum (ER). The aim of this study was to clarify the detailed function of NO on unfolded protein response (UPR) branches. We here found that the ER stress sensor IRE1α is S-nitrosylated. Interestingly, NO specifically abrogates ribonuclease activity, but not oligomerization or autophosphorylation of IRE1α. Site-directed mutagenesis revealed that Cys 931 and Cys951 in IRE1 are targets for S-nitrosylation. These mutants expressing in IRE1α knockout MEF showed a resistant role to the inhibition of nuclease activity by NO. Thus, we elucidated the effects of S-nitrosylation on ER stress sensors that mediate the UPR, and thus contribute to cell death pathways.
- Published
- 2016
- Full Text
- View/download PDF
25. Clinical outcomes of helical tomotherapy for super-elderly patients with localized and locally advanced prostate cancer: comparison with patients under 80 years of age.
- Author
-
Okonogi N, Katoh H, Kawamura H, Tamaki T, Kaminuma T, Murata K, Ohkubo Y, Takakusagi Y, Onishi M, Sekihara T, Okazaki A, and Nakano T
- Subjects
- Aged, Aged, 80 and over, Humans, Male, Prostatic Neoplasms radiotherapy, Radiotherapy, Intensity-Modulated adverse effects
- Abstract
We investigated the clinical outcomes of helical tomotherapy in 23 patients aged ≥80 years with localized and locally advanced prostate cancer and compared the results with data from 171 patients under 80 years. All patients received helical tomotherapy in our hospital between September 2009 and October 2012. The median follow-up periods were 35 months in the aged group and 34 months in the younger group. The median prescribed dose in helical tomotherapy was 78 Gy in 39 fractions (range, 72-78 Gy). The 3-year overall survival and biochemical relapse-free rates were 92% and 96% in the aged group and 99.4% and 97.3% in the younger group, respectively. There was no significant difference between the two groups in the biochemical relapse-free rates. The 3-year cumulative incidences of late Grade 2 or higher rectal toxicity and urinary toxicity were 13% and 4.8% in the aged group and 7.0% and 1.2% in the younger group, respectively. There was no significant difference between the aged group and the younger group in the cumulative incidence rates of rectal toxicity or urinary toxicity. No patients exhibited Grade 4 or higher toxicity, and all patients improved with conservative therapy. Helical tomotherapy in super-elderly patients with localized and locally advanced prostate cancer had good biochemical control rates without severe late toxicity. Definitive helical tomotherapy may be the treatment of choice for patients with localized and locally advanced prostate cancer, even in those older than 80 years of age., (© The Author 2015. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.)
- Published
- 2015
- Full Text
- View/download PDF
26. Regulation of the unfolded protein response via S-nitrosylation of sensors of endoplasmic reticulum stress.
- Author
-
Nakato R, Ohkubo Y, Konishi A, Shibata M, Kaneko Y, Iwawaki T, Nakamura T, Lipton SA, and Uehara T
- Subjects
- Amino Acid Substitution, Animals, Cell Death, Cell Line, Cell Line, Tumor, Cysteine chemistry, Cysteine metabolism, Endoplasmic Reticulum metabolism, Endoribonucleases genetics, Eukaryotic Initiation Factor-2 genetics, Eukaryotic Initiation Factor-2 metabolism, Fibroblasts cytology, Fibroblasts metabolism, Mice, Models, Biological, Mutagenesis, Site-Directed, Neurons cytology, Neurons metabolism, Parkinson Disease genetics, Parkinson Disease metabolism, Parkinson Disease pathology, Phosphorylation, Protein Serine-Threonine Kinases genetics, Serine chemistry, Serine metabolism, Signal Transduction, eIF-2 Kinase genetics, Endoplasmic Reticulum Stress genetics, Endoribonucleases metabolism, Nitric Oxide metabolism, Protein Processing, Post-Translational, Protein Serine-Threonine Kinases metabolism, Unfolded Protein Response genetics, eIF-2 Kinase metabolism
- Abstract
Protein S-nitrosylation modulates important cellular processes, including neurotransmission, vasodilation, proliferation, and apoptosis in various cell types. We have previously reported that protein disulfide isomerase (PDI) is S-nitrosylated in brains of patients with sporadic neurodegenerative diseases. This modification inhibits PDI enzymatic activity and consequently leads to the accumulation of unfolded/misfolded proteins in the endoplasmic reticulum (ER) lumen. Here, we describe S-nitrosylation of additional ER pathways that affect the unfolded protein response (UPR) in cell-based models of Parkinson's disease (PD). We demonstrate that nitric oxide (NO) can S-nitrosylate the ER stress sensors IRE1α and PERK. While S-nitrosylation of IRE1α inhibited its ribonuclease activity, S-nitrosylation of PERK activated its kinase activity and downstream phosphorylation/inactivation or eIF2α. Site-directed mutagenesis of IRE1α(Cys931) prevented S-nitrosylation and inhibition of its ribonuclease activity, indicating that Cys931 is the predominant site of S-nitrosylation. Importantly, cells overexpressing mutant IRE1α(C931S) were resistant to NO-induced damage. Our findings show that nitrosative stress leads to dysfunctional ER stress signaling, thus contributing to neuronal cell death.
- Published
- 2015
- Full Text
- View/download PDF
27. Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats.
- Author
-
Imaeda M, Ishikawa H, Yoshida Y, Takahashi T, Ohkubo Y, Musha A, Komachi M, Nakazato Y, and Nakano T
- Subjects
- Actins metabolism, Animals, Apoptosis radiation effects, Cell Proliferation radiation effects, Disease Progression, Dose-Response Relationship, Radiation, Immunohistochemistry, Intraoperative Period, Liver metabolism, Liver pathology, Liver Cirrhosis etiology, Liver Cirrhosis metabolism, Liver Cirrhosis pathology, Male, Rats, Rats, Wistar, Transforming Growth Factor beta1 metabolism, Liver radiation effects, Radiation Injuries, Experimental metabolism, Radiation Injuries, Experimental pathology
- Abstract
Radiation therapy (RT) has become particularly important recently for treatment of liver tumors, but there are few experimental investigations pertaining to radiation-induced liver injuries over long-term follow-up periods. Thus, the present study examined pathological liver features over a 10-month period using an intraoperative whole-liver irradiation model. Liver function tests were performed in blood samples, whereas cell death, cell proliferation, and fibrotic changes were evaluated pathologically in liver tissues, which were collected from irradiated rats 24 h, 1, 2, 4 and 40 weeks following administration of single irradiation doses of 0 (control), 15 or 30 Gy. The impaired liver function, increased hepatocyte number, and decreased apoptotic cell proportion observed in the 15 Gy group, but not the 30 Gy group, returned to control group levels after 40 weeks; however, the Ki-67 indexes in the 15 Gy group were still higher than those in the control group after 40 weeks. Azan staining showed a fibrotic pattern in the irradiated liver in the 30 Gy group only, but the expression levels of alpha smooth muscle actin (α-SMA) and transforming growth factor-beta 1 (TGF-β1) in both the 15 and 30 Gy groups were significantly higher than those in the control group (P < 0.05). There were differences in the pathological features of the irradiated livers between the 15 Gy and 30 Gy groups, but TGF-β1 and α-SMA expression patterns supported the gradual progression of radiation-induced liver fibrosis in both groups. These findings will be useful in the future development of protective drugs for radiation-induced liver injury., (© The Author 2014. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.)
- Published
- 2014
- Full Text
- View/download PDF
28. Dose volume analysis of radiotherapy for inoperable patients with stage I-II endometrial carcinoma.
- Author
-
Ohkubo Y, Kato S, Kiyohara H, Tsuruoka I, Tamaki T, Noda SE, Ohno T, and Nakano T
- Subjects
- Aged, Aged, 80 and over, Brachytherapy, Carcinoma, Endometrioid diagnostic imaging, Carcinoma, Endometrioid pathology, Endometrial Neoplasms diagnostic imaging, Endometrial Neoplasms pathology, Female, Humans, Imaging, Three-Dimensional, Middle Aged, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Tomography, X-Ray Computed, Treatment Outcome, Carcinoma, Endometrioid radiotherapy, Endometrial Neoplasms radiotherapy
- Abstract
This study aims to assess the efficacy and toxicity of definitive radiotherapy for early-stage endometrial carcinoma. The correlation between CT-based dosimetric parameters and clinical outcomes is also evaluated. Between 2002 and 2006, 10 medically inoperable patients with T1-2 endometrial carcinoma were treated with radiotherapy alone. A combination of external beam radiotherapy (EBRT) and high-dose-rate intracavitary brachytherapy (HDR-ICBT) was used for 9 patients, and one was treated with HDR-ICBT alone. Dose prescription of HDR-ICBT was determined in reference to CT images at brachytherapy, and a total dose of 22-24 Gy in 4 fractions was delivered to the outer perimeter of the uterine corpus. Dose-volume parameters of the gross tumor volume (GTV), clinical target volume (CTV), and organs at risk were assessed retrospectively using the dose-volume histograms derived from the CT image-based treatment planning system. After a median follow-up of 55 months, 9 patients were alive without evidence of recurrence. One patient died from liver cirrhosis 17 months after radiotherapy. Severe acute and late toxicities were not observed in any of the patients. Average minimum dose to 90% of GTV and CTV (D90) was 88.0 and 45.9 Gy(EQD2), respectively. The minimum dose delivered to 2 cc of the most irradiated volumes of the rectum and sigmoid colon (D(2cc)) was 78.9 and 65.9 Gy(EQD2), respectively. These patients developed Grade 1 late complications. In this study, stage I-II endometrial carcinoma was well-controlled locally with minimum late toxicity by radiotherapy alone with HDR-ICBT. 3D image-based brachytherapy may potentially deliver a sufficiently high dose to the whole tumor without significant increase in dose to surrounding normal tissues.
- Published
- 2011
- Full Text
- View/download PDF
29. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
- Author
-
Kato S, Tran DN, Ohno T, Nakano T, Kiyohara H, Ohkubo Y, and Kamada T
- Subjects
- Adenocarcinoma diagnostic imaging, Adult, Aged, Aged, 80 and over, Brachytherapy methods, Carcinoma, Squamous Cell diagnostic imaging, Dose-Response Relationship, Radiation, Female, Humans, Iridium Radioisotopes adverse effects, Middle Aged, Organ Size, Radiation Injuries etiology, Radiation Protection instrumentation, Radiometry, Radiotherapy Dosage, Radiotherapy, High-Energy adverse effects, Rectal Diseases etiology, Uterine Cervical Neoplasms diagnostic imaging, Adenocarcinoma radiotherapy, Brachytherapy adverse effects, Carcinoma, Squamous Cell radiotherapy, Imaging, Three-Dimensional, Iridium Radioisotopes therapeutic use, Radiation Injuries diagnostic imaging, Rectal Diseases diagnostic imaging, Rectum radiation effects, Tomography, X-Ray Computed methods, Uterine Cervical Neoplasms radiotherapy
- Abstract
This study evaluated the efficacy of computed tomography (CT)-based three-dimensional (3D) dose-volume parameters of the rectum as predictor for late rectal complication (LRC) in cervical cancer patients treated with radiotherapy alone. Eighty-four patients treated with a combination of external radiotherapy and high-dose-rate intracavitary brachytherapy between January 2000 and December 2004 were retrospectively analyzed. Brachytherapy was prescribed with standard 2D planning. Patients underwent pelvic CT at brachytherapy. The external rectal wall was contoured on the CT images, and the minimum doses delivered to 0.1cc, 1cc, and 2cc of the most irradiated rectal volumes were calculated with dose-volume histograms. The International Commission of Radiation Units and Measurements (ICRU) rectal point dose was also calculated by conventional method. Total dose (external radiotherapy plus brachytherapy) to the rectum was transformed to the biologically equivalent dose in 2-Gy fractions with alpha/beta of 3 Gy (D(0.1cc), D(1cc), D(2cc) and D(ICRU)). The relationships between these dosimetric parameters and the incidence of LRC were analyzed. The 5-year overall actuarial rate of LRC was 26.4%. The values of D(0.1cc), D(1cc), and D(2cc) were significantly higher in patients with LRC than in those without (p < 0.001), but the difference in the values of D(ICRU) was not statistically significant (p = 0.10). The rate of LRC increased significantly with increasing D(0.1cc), D(1cc), and D(2cc) (p = 0.001). However, no positive dose-response relationship was observed between D(ICRU) and the rate of LRC (p = 0.42). The present study has suggested that CT-based 3D dose-volume parameters of the rectum may be effective for predicting LRC.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.